COMPANY PROFILE

Innate Pharma - ADR

Chart

Overview

Financials

Related Articles

Five Fallen Biotech Stocks We’re Watching for Rebounds

Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins